Efficacy and Safety of TAK-242 in Patients With Sepsis-Induced Cardiovascular and Respiratory Failure

This study has been terminated.

( Business Decision; No Safety Or Efficacy Concerns. )

Study NCT00633477 Information provided by Takeda Global Research & Development Center, Inc.

First Received: March 4, 2008 Last Updated: March 11, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2009
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)